A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

NCT06496971 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme
Glioblastoma
Glioblastoma Multiforme, Adult
Glioma
Brain Tumor
Brain Tumor, Recurrent
Neoplasms
Neoplasms, Nerve Tissue

Interventions

DRUG: Bevacizumab
DRUG: Microbubble
DEVICE: Low-Intensity Focused Ultrasound

Sponsor

NaviFUS Corporation